CLINICAL RESEARCH: MAGNETIC RESONANCE AND COMPUTED TOMOGRAPHIC IMAGING
The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy
James C. C. Moon, MB, BCh*,
Emma Reed ,
Mary N. Sheppard, FRCPath,
Andrew G. Elkington, MB, BCh*,
SiewYen Ho, PhD, FRCPath ,
Margaret Burke, MB, FRCPath,
Mario Petrou, PhD, FRCS and
Dudley J. Pennell, MD, FRCP, FESC, FACC*,*
* Centre for Advanced Magnetic Resonance in Cardiology (CAMRIC), London, United Kingdom
Department of Histopathology, Royal Brompton and Harefield Hospitals, London, United Kingdom
Department of Paediatrics, Royal Brompton and Harefield Hospitals, London, United Kingdom
Department of Cardiothoracic Surgery, Royal Brompton and Harefield Hospitals, London, United Kingdom
Manuscript received June 18, 2003;
revised manuscript received February 18, 2004,
accepted March 2, 2004.
* Reprint requests and correspondence: Dr. Dudley J. Pennell, Professor of Cardiology, CMR Unit, Royal Brompton Hospital, Sydney Street, London SW3 6NP, United Kingdom.
d.pennell{at}ic.ac.uk
OBJECTIVES: We sought to identify the histologic basis of myocardial late gadolinium enhancement cardiovascular magnetic resonance (CMR) in hypertrophic cardiomyopathy (HCM).
BACKGROUND: The histologic basis of late gadolinium CMR in patients with HCM is unknown.
METHODS: A 28-year-old male patient with HCM and heart failure underwent late gadolinium enhancement CMR and, 49 days later, heart transplantation. The explanted heart was examined histologically for the extent of collagen and disarray, and the results were compared with a previous in vivo CMR scan.
RESULTS: Overall, 19% of the myocardium was collagen, but the amount per segment varied widely (SD ± 19, range 0% to 71%). Both disarray and collagen were more likely to be found in the mesocardium than in the endo- or epicardium. There was a significant relationship between the extent of late gadolinium enhancement and collagen (r = 0.7, p < 0.0001) but not myocardial disarray (p = 0.58). Segments containing >15% collagen were more likely to have late gadolinium enhancement. Regional wall motion was inversely related to the extent of myocardial collagen and late gadolinium enhancement but not disarray (p = 0.0003, 0.04, and NS, respectively).
CONCLUSIONS: In this patient with HCM and heart failure, regions of myocardial late gadolinium enhancement by CMR represented regions of increased myocardial collagen but not disarray.
|
Abbreviations and Acronyms
| | CMR | = cardiovascular magnetic resonance | | HCM | = hypertrophic cardiomyopathy | | LV | = left ventricle/ventricular | | RV | = right ventricular |
|
This article has been cited by other articles:
|
|
|
|
 
E. Belloni, F. De Cobelli, A. Esposito, R. Mellone, G. Perseghin, T. Canu, and A. Del Maschio
MRI of Cardiomyopathy
Am. J. Roentgenol.,
December 1, 2008;
191(6):
1702 - 1710.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T BRAHMBHATT, P HARI, M CINQUEGRANI, N KUMAR, R KOMOROWSKI, and R Q MIGRINO
Delayed enhancement on cardiac MRI in a patient with multiple myeloma without amyloidosis
Br. J. Radiol.,
November 1, 2008;
81(971):
e272 - e275.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W P Bandettini and A E Arai
Advances in clinical applications of cardiovascular magnetic resonance imaging
Heart,
November 1, 2008;
94(11):
1485 - 1495.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Gonzalez, B. Lopez, S. Ravassa, J. Beaumont, T. Arias, N. Hermida, A. Zudaire, and J. Diez
Biochemical markers of myocardial remodelling in hypertensive heart disease
Cardiovasc Res,
September 20, 2008;
(2008)
cvn235v2.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. S. Maron, E. Appelbaum, C. J. Harrigan, J. Buros, C. M. Gibson, C. Hanna, J. R. Lesser, J. E. Udelson, W. J. Manning, and B. J. Maron
Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy
Circ Heart Fail,
September 1, 2008;
1(3):
184 - 191.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. E.J. Thomson
Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: diagnostic value of a typical pattern of late gadolinium enhancement.
J. Am. Coll. Cardiol.,
March 11, 2008;
51(10):
1031 - 1032.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. W. Hansen and N. Merchant
MRI of Hypertrophic Cardiomyopathy: Part I, MRI Appearances
Am. J. Roentgenol.,
December 1, 2007;
189(6):
1335 - 1343.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U Sechtem, H Mahrholdt, and H Vogelsberg
Cardiac magnetic resonance in myocardial disease
Heart,
December 1, 2007;
93(12):
1520 - 1527.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. G. Assomull, J. C. Lyne, N. Keenan, A. Gulati, N. H. Bunce, S. W. Davies, D. J. Pennell, and S. K. Prasad
The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries
Eur. Heart J.,
May 3, 2007;
(2007)
ehm113v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Harris, T. R. Johnson, P. M. Weinberg, and M. A. Fogel
Delayed-enhancement cardiovascular magnetic resonance identifies fibrous tissue in children after surgery for congenital heart disease
J. Thorac. Cardiovasc. Surg.,
March 1, 2007;
133(3):
676 - 681.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. P. McCann, C. T. Gan, A. M. Beek, H. W. M. Niessen, A. V. Noordegraaf, and A. C. van Rossum
Extent of MRI Delayed Enhancement of Myocardial Mass Is Related to Right Ventricular Dysfunction in Pulmonary Artery Hypertension
Am. J. Roentgenol.,
February 1, 2007;
188(2):
349 - 355.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Germans, A. A.M. Wilde, P. A. Dijkmans, W. Chai, O. Kamp, Y. M. Pinto, and A. C. van Rossum
Structural Abnormalities of the Inferoseptal Left Ventricular Wall Detected by Cardiac Magnetic Resonance Imaging in Carriers of Hypertrophic Cardiomyopathy Mutations
J. Am. Coll. Cardiol.,
December 19, 2006;
48(12):
2518 - 2523.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. F. Nagueh and J. J. Mahmarian
Noninvasive Cardiac Imaging in Patients With Hypertrophic Cardiomyopathy
J. Am. Coll. Cardiol.,
December 19, 2006;
48(12):
2410 - 2422.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. M. Harris, P. Spirito, M. S. Maron, A. G. Zenovich, F. Formisano, J. R. Lesser, S. Mackey-Bojack, W. J. Manning, J. E. Udelson, and B. J. Maron
Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy
Circulation,
July 18, 2006;
114(3):
216 - 225.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. De Cobelli, M. Pieroni, A. Esposito, C. Chimenti, E. Belloni, R. Mellone, T. Canu, G. Perseghin, C. Gaudio, A. Maseri, et al.
Delayed Gadolinium-Enhanced Cardiac Magnetic Resonance in Patients With Chronic Myocarditis Presenting With Heart Failure or Recurrent Arrhythmias
J. Am. Coll. Cardiol.,
April 18, 2006;
47(8):
1649 - 1654.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P A Davlouros, K Niwa, G Webb, and M A Gatzoulis
The right ventricle in congenital heart disease
Heart,
April 1, 2006;
92(suppl_1):
i27 - i38.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. V. Babu-Narayan, P. J. Kilner, W. Li, J. C. Moon, O. Goktekin, P. A. Davlouros, M. Khan, S. Y. Ho, D. J. Pennell, and M. A. Gatzoulis
Ventricular Fibrosis Suggested by Cardiovascular Magnetic Resonance in Adults With Repaired Tetralogy of Fallot and Its Relationship to Adverse Markers of Clinical Outcome
Circulation,
January 24, 2006;
113(3):
405 - 413.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. G. Blyth, B. A. Groenning, T. N. Martin, J. E. Foster, P. B. Mark, H. J. Dargie, and A. J. Peacock
Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension
Eur. Heart J.,
October 1, 2005;
26(19):
1993 - 1999.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Rickers, N. M. Wilke, M. Jerosch-Herold, S. A. Casey, P. Panse, N. Panse, J. Weil, A. G. Zenovich, and B. J. Maron
Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy
Circulation,
August 9, 2005;
112(6):
855 - 861.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Mahrholdt, A. Wagner, R. M. Judd, U. Sechtem, and R. J. Kim
Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies
Eur. Heart J.,
August 1, 2005;
26(15):
1461 - 1474.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J C Moon, J Mogensen, P M Elliott, G C Smith, A G Elkington, S K Prasad, D J Pennell, and W J McKenna
Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I
Heart,
August 1, 2005;
91(8):
1036 - 1040.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-P. Smedema, G. Snoep, M. P. G. van Kroonenburgh, R.-J. van Geuns, W. R. M. Dassen, A. P. Gorgels, and H. J. G. M. Crijns
Cardiac Involvement in Patients With Pulmonary Sarcoidosis Assessed at Two University Medical Centers in the Netherlands
Chest,
July 1, 2005;
128(1):
30 - 35.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Tadamura, M. Yamamuro, S. Kubo, S. Kanao, T. Saga, M. Harada, M. Ohba, R. Hosokawa, T. Kimura, T. Kita, et al.
Effectiveness of Delayed Enhanced MRI for Identification of Cardiac Sarcoidosis: Comparison with Radionuclide Imaging
Am. J. Roentgenol.,
July 1, 2005;
185(1):
110 - 115.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. P. Liu and A. T. Yan
Cardiovascular Magnetic Resonance for the Diagnosis of Acute Myocarditis: Prospects for Detecting Myocardial Inflammation
J. Am. Coll. Cardiol.,
June 7, 2005;
45(11):
1823 - 1825.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Knaapen, W. G. van Dockum, O. Bondarenko, W. E.M. Kok, M. J.W. Gotte, R. Boellaard, A. M. Beek, C. A. Visser, A. C. van Rossum, A. A. Lammertsma, et al.
Delayed Contrast Enhancement and Perfusable Tissue Index in Hypertrophic Cardiomyopathy: Comparison Between Cardiac MRI and PET
J. Nucl. Med.,
June 1, 2005;
46(6):
923 - 929.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-P. Smedema, G. Snoep, M. P.G. van Kroonenburgh, R.-J. van Geuns, W. R.M. Dassen, A. P.M. Gorgels, and H. J.G.M. Crijns
Evaluation of the Accuracy of Gadolinium-Enhanced Cardiovascular Magnetic Resonance in the Diagnosis of Cardiac Sarcoidosis
J. Am. Coll. Cardiol.,
May 17, 2005;
45(10):
1683 - 1690.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Soriano, F. Ridocci, J. Estornell, J. Jimenez, V. Martinez, and J. A. De Velasco
Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance
J. Am. Coll. Cardiol.,
March 1, 2005;
45(5):
743 - 748.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Y. Kwong and R. H. Falk
Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
Circulation,
January 18, 2005;
111(2):
122 - 124.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Maceira, J. Joshi, S. K. Prasad, J. C. Moon, E. Perugini, I. Harding, M. N. Sheppard, P. A. Poole-Wilson, P. N. Hawkins, and D. J. Pennell
Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
Circulation,
January 18, 2005;
111(2):
186 - 193.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Pennell, U. P. Sechtem, C. B. Higgins, W. J. Manning, G. M. Pohost, F. E. Rademakers, A. C. van Rossum, L. J. Shaw, and E. K. Yucel
Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report
Eur. Heart J.,
November 1, 2004;
25(21):
1940 - 1965.
[Full Text]
[PDF]
|
|
|
|
